J Glaucoma 2021 Mar 5. Epub 2021 Mar 5.
Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic Medical Scientist Training Program, Rochester, MN, USA Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Prcis: In this longitudinal study of patients with open-angle, pseudoexfoliative, or neovascular glaucoma receiving glaucoma drainage devices, post-tube cumulative rates of reoperation, corneal graft, and visually threatening complications increased beyond 5 years and were not significantly affected by glaucoma type.
Purpose: To study the need for additional glaucoma surgery and development of complications after first glaucoma drainage device (GDD) surgery in eyes with primary open-angle (OAG), pseudoexfoliative (PXE), or neovascular (NVG) glaucoma.
Patients And Methods: There were 306 eyes with OAG (n=185), PXE (n=60), or NVG (n=61) glaucoma who received a first GDD between 1996 and 2017. Read More